OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanism of degrader-targeted protein ubiquitinability
Charlotte Crowe, Mark A. Nakasone, Sarah Chandler, et al.
Science Advances (2024) Vol. 10, Iss. 41
Open Access | Times Cited: 8

Showing 8 citing articles:

Selective degradation of BRD9 by a DCAF16-recruiting targeted glue: mode of action elucidation and in vivo proof of concept
Scott J. Hughes, Wojciech J. Stec, Colin Davies, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access

Allostery in Disease: Anticancer Drugs, Pockets, and the Tumor Heterogeneity Challenge
Ruth Nussinov, Bengi Ruken Yavuz, Hyunbum Jang
Journal of Molecular Biology (2025), pp. 169050-169050
Open Access

Advancing target validation with PROTAC technology
Margaret Spitz, Aseel Kashkush, Raphael I. Benhamou
Expert Opinion on Drug Discovery (2025)
Closed Access

Targeted Protein Degradation: From Basic Science to Therapeutic Applications
Rongkun Zhu, Xiaoyu Tang, Heng Zhang
ACS Chemical Biology (2025)
Closed Access

Characterization of PROTACs by Ternary Complex Landscape Exploration using Monte Carlo simulations
Anna M. Díaz-Rovira, Carles Perez‐Lopez, Jordi Martín-Pérez, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access

Targeted protein degradation for cancer therapy
Matthias Hinterndorfer, Valentina A. Spiteri, Alessio Ciulli, et al.
Nature reviews. Cancer (2025)
Closed Access

A patent review of von Hippel-Lindau (vhl)-recruiting chemical matter: E3 ligase ligands for PROTACs and targeted protein degradation (2019-present)
Aina Urbina, Alex J. Hallatt, Jack Robertson, et al.
Expert Opinion on Therapeutic Patents (2025), pp. 1-42
Closed Access

Mechanism of cooperative strigolactone perception by the MAX2 ubiquitin ligase-receptor-substrate complex
Alexandra I. Vancea, Brandon Huntington, Wieland Steinchen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Page 1

Scroll to top